02/14/2025
4:49 PM | ARMISTICE CAPITAL, LLC (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:27 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
01/31/2025
10:44 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
4:29 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2025
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IRWD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/29/2025
3:10 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:38 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:35 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:43 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:00 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
1:41 PM | Ironwood Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
11/12/2024
2:47 PM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
4:22 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:46 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
9:04 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/30/2024
6:00 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
6:30 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
12:35 PM | Ironwood Pharmaceuticals (Subject)
Moukheibir Catherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
3:46 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:09 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:26 PM | Ironwood Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:28 PM | Ironwood Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:31 PM | Ironwood Pharmaceuticals (Filer)
| Form ARS | |
